These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1548080)

  • 1. Improved rat model of Pneumocystis carinii pneumonia: induced laboratory infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    Infect Immun; 1992 Apr; 60(4):1589-97. PubMed ID: 1548080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An improved rat model of Pneumocystis carinii pneumonia: induced infections in Pneumocystis-free animals.
    Boylan CJ; Current WL
    J Protozool; 1991; 38(6):138S-140S. PubMed ID: 1818140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumocystis carinii: improved models to study efficacy of drugs for treatment or prophylaxis of Pneumocystis pneumonia in the rat (Rattus spp.).
    Bartlett MS; Fishman JA; Durkin MM; Queener SF; Smith JW
    Exp Parasitol; 1990 Jan; 70(1):100-6. PubMed ID: 2295322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An animal model of Pneumocystis carinii pneumonia and therapeutic efficacy of interferon-gamma in this model].
    Nakamoto A; Kitsukawa K; Ishimine T; Inadome J; Kusano N; Fukuhara H; Saito A
    Kansenshogaku Zasshi; 1993 Oct; 67(10):971-7. PubMed ID: 8254217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sources of rats free of latent Pneumocystis carinii.
    Bartlett MS; Durkin MM; Jay MA; Queener SF; Smith JW
    J Clin Microbiol; 1987 Sep; 25(9):1794-5. PubMed ID: 2958497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An improved method for the prolonged maintenance of Pneumocystis carinii in vitro.
    Mirovsky P; Fishman JA
    J Infect Dis; 1993 Jun; 167(6):1470-3. PubMed ID: 8501343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of DL-alpha-difluoromethylornithine in a rat model of Pneumocystis carinii pneumonia.
    Clarkson AB; Williams DE; Rosenberg C
    Antimicrob Agents Chemother; 1988 Aug; 32(8):1158-63. PubMed ID: 3142346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pneumocystis carinii pneumonia therapy with 9-deazainosine in rats.
    Smith JW; Bartlett MS; Queener SF; Durkin MM; Jay MA; Hull MT; Klein RS; Marr JJ
    Diagn Microbiol Infect Dis; 1987 Jun; 7(2):113-8. PubMed ID: 3498606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inoculated mouse model of Pneumocystis carinii pneumonia.
    Bartlett MS; Queener SF; Durkin MM; Shaw MM; Smith JW
    J Protozool; 1991; 38(6):130S-131S. PubMed ID: 1818136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial infections of Pneumocystis carinii in the SCID mouse and their use in the in vivo evaluation of antipneumocystis drugs.
    Comley JC; Sterling AM
    J Eukaryot Microbiol; 1994; 41(6):540-6. PubMed ID: 7866380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of dosages, intervals, and drugs in the prevention of Pneumocystis carinii pneumonia.
    Hughes WT
    Antimicrob Agents Chemother; 1988 May; 32(5):623-5. PubMed ID: 3260765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of corticosteroid- and L3T4+ antibody-immunosuppressed mouse models of Pneumocystis carinii pneumonia for evaluation of drugs and leukocytes.
    Bartlett MS; Current WL; Orazi A; Bauer NL; Neiman RS; Queener SF; Smith JW
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):511-6. PubMed ID: 8556494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surfactant phospholipids and lavage phospholipase A2 in experimental Pneumocystis carinii pneumonia.
    Sheehan PM; Stokes DC; Yeh YY; Hughes WT
    Am Rev Respir Dis; 1986 Sep; 134(3):526-31. PubMed ID: 3489425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of folinic acid on the capacity of trimethoprim-sulfamethoxazole to prevent and treat Pneumocystis carinii pneumonia in rats.
    D'Antonio RG; Johnson DB; Winn RE; van Dellen AF; Evans ME
    Antimicrob Agents Chemother; 1986 Feb; 29(2):327-9. PubMed ID: 3487285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of experimental Pneumocystis carinii infection by combination of clarithromycin and sulphamethoxazole.
    Alder J; Mitten M; Shipkowitz N; Hernandez L; Hui YH; Marsh K; Clement J
    J Antimicrob Chemother; 1994 Feb; 33(2):253-63. PubMed ID: 8182006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of organism burden and alveolar macrophage counts during infection with Pneumocystis carinii and recovery.
    Lasbury ME; Durant PJ; Bartlett MS; Smith JW; Lee CH
    Clin Diagn Lab Immunol; 2003 Mar; 10(2):293-302. PubMed ID: 12626457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis.
    Hughes WT; Gray VL; Gutteridge WE; Latter VS; Pudney M
    Antimicrob Agents Chemother; 1990 Feb; 34(2):225-8. PubMed ID: 2327770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New rat model of Pneumocystis carinii infection.
    Bartlett MS; Fishman JA; Queener SF; Durkin MM; Jay MA; Smith JW
    J Clin Microbiol; 1988 Jun; 26(6):1100-2. PubMed ID: 3260241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of terbinafine against Pneumocystis carinii in vitro and its efficacy in the treatment of experimental pneumonia.
    Contini C; Manganaro M; Romani R; Tzantzoglou S; Poggesi I; Vullo V; Delia S; De Simone C
    J Antimicrob Chemother; 1994 Nov; 34(5):727-35. PubMed ID: 7706168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipid composition of Pneumocystis carinii carinii and effects of methylprednisolone immunosuppression on rat lung lipids.
    Guo Z; Kaneshiro ES
    Infect Immun; 1995 Apr; 63(4):1286-90. PubMed ID: 7890386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.